OPKO Health Operating Expenses 2010-2024 | OPK

OPKO Health operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
OPKO Health Annual Operating Expenses
(Millions of US $)
2023 $1,021
2022 $1,230
2021 $1,756
2020 $1,378
2019 $1,176
2018 $1,161
2017 $1,242
2016 $1,214
2015 $590
2014 $237
2013 $176
2012 $84
2011 $51
2010 $40
2009 $27
OPKO Health Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $159
2024-06-30 $244
2024-03-31 $245
2023-12-31 $251
2023-09-30 $243
2023-06-30 $258
2023-03-31 $268
2022-12-31 $241
2022-09-30 $268
2022-06-30 $321
2022-03-31 $402
2021-12-31 $464
2021-09-30 $348
2021-06-30 $437
2021-03-31 $507
2020-12-31 $445
2020-09-30 $406
2020-06-30 $274
2020-03-31 $252
2019-12-31 $337
2019-09-30 $268
2019-06-30 $274
2019-03-31 $298
2018-12-31 $312
2018-09-30 $283
2018-06-30 $269
2018-03-31 $298
2017-12-31 $319
2017-09-30 $294
2017-06-30 $318
2017-03-31 $312
2016-12-31 $245
2016-09-30 $322
2016-06-30 $329
2016-03-31 $319
2015-12-31 $284
2015-09-30 $151
2015-06-30 $68
2015-03-31 $87
2014-12-31 $58
2014-09-30 $68
2014-06-30 $58
2014-03-31 $53
2013-12-31 $57
2013-09-30 $40
2013-06-30 $42
2013-03-31 $38
2012-12-31 $26
2012-09-30 $21
2012-06-30 $20
2012-03-31 $18
2011-12-31 $14
2011-09-30 $13
2011-06-30 $13
2011-03-31 $11
2010-12-31 $5
2010-09-30 $10
2010-06-30 $13
2010-03-31 $12
2009-12-31 $1
2009-09-30 $7
2009-06-30 $8
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.174B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $210.506B 96.57
Thermo Fisher Scientific (TMO) United States $202.042B 24.50
Alcon (ALC) Switzerland $44.047B 29.47
Edwards Lifesciences (EW) United States $42.914B 27.77
IDEXX Laboratories (IDXX) United States $37.709B 43.46
DexCom (DXCM) United States $35.463B 55.00
IQVIA Holdings (IQV) United States $34.295B 19.00
Mettler-Toledo (MTD) United States $27.400B 31.83
Waters (WAT) United States $22.520B 31.95
STERIS (STE) Ireland $21.977B 25.13
SONOVA HOLDING (SONVY) Switzerland $19.361B 0.00
Hologic (HOLX) United States $14.588B 15.74
Fresenius Medical Care AG KGaA (FMS) Germany $13.679B 14.04
Sysmex ADR (SSMXY) Japan $11.343B 35.57
Penumbra (PEN) United States $11.081B 100.24
Globus Medical (GMED) United States $10.896B 25.48
Masimo (MASI) United States $9.140B 44.23
Teleflex (TFX) United States $8.250B 13.16
Glaukos (GKOS) United States $6.850B 0.00
Integer Holdings (ITGR) United States $4.269B 23.96
PROCEPT BioRobotics (PRCT) United States $3.400B 0.00
Veracyte (VCYT) United States $3.050B 55.44
LivaNova (LIVN) United Kingdom $2.688B 15.52
Nihon Kohden (NHNKY) Japan $2.652B 14.49
TransMedics (TMDX) United States $2.588B 82.04
Elekta AB (EKTAY) Sweden $2.198B 19.76
Tandem Diabetes Care (TNDM) United States $2.145B 0.00
Integra LifeSciences Holdings (IART) United States $1.701B 8.89
Alphatec Holdings (ATEC) United States $1.526B 0.00
RxSight (RXST) United States $1.181B 0.00
Artivion (AORT) United States $1.167B 111.40
Pulse Biosciences (PLSE) United States $1.154B 0.00
Paragon 28 (FNA) United States $1.092B 0.00
Beta Bionics (BBNX) United States $0.883B 0.00
AxoGen (AXGN) United States $0.793B 0.00
Mesa Laboratories (MLAB) United States $0.791B 17.30
SiBone (SIBN) United States $0.733B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.718B 12.21
IRadimed (IRMD) United States $0.699B 36.76
ORTHOFIX MEDICAL INC (OFIX) United States $0.694B 0.00
Treace Medical Concepts (TMCI) United States $0.597B 0.00
OrthoPediatrics (KIDS) United States $0.569B 0.00
ClearPoint Neuro (CLPT) United States $0.452B 0.00
Delcath Systems (DCTH) United States $0.449B 0.00
Pacific Biosciences Of California (PACB) United States $0.446B 0.00
Semler Scientific (SMLR) United States $0.411B 9.04
AngioDynamics (ANGO) United States $0.408B 0.00
NeuroPace (NPCE) United States $0.404B 0.00
Tactile Systems Technology (TCMD) United States $0.351B 18.86
CVRx (CVRX) United States $0.343B 0.00
Anteris Technologies Global (AVR) Australia $0.261B 0.00
Inogen (INGN) United States $0.234B 0.00
Nevro (NVRO) United States $0.214B 0.00
Accuray (ARAY) United States $0.212B 0.00
Alpha Tau Medical (DRTS) Israel $0.192B 0.00
KORU Medical Systems (KRMD) United States $0.169B 0.00
Spectral Diagnostics (EDTXF) Canada $0.151B 0.00
Neuronetics (STIM) United States $0.135B 0.00
Sight Sciences (SGHT) United States $0.125B 0.00
Rapid Micro Biosystems (RPID) United States $0.121B 0.00
LENSAR (LNSR) United States $0.108B 0.00
Atossa Genetics (ATOS) United States $0.099B 0.00
InspireMD (NSPR) Israel $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.093B 0.00
908 Devices (MASS) United States $0.089B 0.00
Sensus Healthcare (SRTS) United States $0.085B 12.98
Lucid Diagnostics (LUCD) United States $0.082B 0.00
Vicarious Surgical (RBOT) United States $0.081B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Covalon Technologies (CVALF) Canada $0.055B 16.58
Microbot Medical (MBOT) United States $0.054B 0.00
Positron (POSC) United States $0.052B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Baird Medical Investment Holdings (BDMD) $0.029B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
Adagio Medical Holdings (ADGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.021B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
WORK Medical Technology Group (WOK) China $0.014B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Autonomix Medical (AMIX) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Tenon Medical (TNON) United States $0.004B 0.00
Aspira Women's Health (AWH) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00